Tevogen Inc.

Item Amendments 5.03 to Articles of Incorporation or Bylaws; Change in Fiscal Year. On July 29, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a certificate of amendment (the “Certificate of Amendment”) to its Certificate of Incorporation, as amended, solely to change the Company’s name from “Tevogen Bio Holdings Inc.” to “Tevogen Inc.” The name change became effective on July 30, 2026. A copy of the Certificate of Amendment is attached hereto as Exhibit 3.1 and incorporated herein by reference. In connection with the name change, the Company’s Board of Directors approved an amendment (the “Bylaws Amendment”) to the Company’s Amended and Restated Bylaws (the “Bylaws”), to reflect the change in the Company’s name, also effective July 30, 2026. No other changes were made to the Bylaws. A copy of the Bylaws, as amended by the Bylaws Amendment, is attached as Exhibit 3.2 hereto and incorporated herein by reference. The Company’s common stock and public warrants continue to trade on the Nasdaq Global Market under the ticker symbols “TVGN” and “TVGN”, respectively. The name change does not affect the rights of the Company’s security holders and the CUSIP numbers for the Company’s common stock and public warrants will continue to be 88165K200 and 88165K119, respectively.